Nasal allergen challenge studies of allergic rhinitis: a guide for the practicing clinician

Annals of Allergy, Asthma & Immunology

September 2014 Volume 113, Issue 3, Pages 250-256

Overall Purpose:
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices.

Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma&Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee Members:

Anne K. Ellis, MD, MSc, FRCPC (Author)

Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)

Gailen D. Marshall, Jr., MD, PhD (Editor-in-Chief)

Target Audience

Physicians involved in providing patient care in the field of allergy/asthma/immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Describe nasal allergen challenge (NAC) methodology
  • Discuss how the NAC study designs, objective measures and biological sampling techniques inform studies of the pathophysiology of allergic rhinitis and clinical efficacy of novel therapies for allergic rhinitis
Additional information
Disclosure: 

A.K. Ellis has received research grants from GlaxoSmithKline and Circassia. M.H.Grayson has received research grants fromChildren’s Research Institute/ Medical College of Wisconsin, Merck, National Institutes of Health (NIH), and Polyphor. G.D. Marshall has received research grants from Amgen, AstraZeneca, and National Institutes ofHealth (NIH). M.L. North,M. Soliman, J. Thiele, D.E. Adams, and L.M. Steacy, have nothing to disclose. Reviewers and Education/Editorial staff have no relevant financial relationships to disclose. No unapproved/investigative use of a product/device is discussed.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
09/01/2014
Course expires: 
08/31/2016
Cost:
$0.00

Mena Soliman, MB ChB; Michelle L. North, PhD; Lisa M. Steacy, BSc; Jenny Thiele, MSc; Daniel E. Adams, BSc; and Anne K. Ellis, MD, MSc, FRCPC

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
09/01/2014
Course expires: 
08/31/2016

Price

Cost:
$0.00
Please login or create an account to take this course.